---
$id: https://graph.org.ai/products/commodity/51141570
$type: Product
source: UNSPSC
code: "51141570"
title: "Riluzole"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Riluzole

**UNSPSC Code**: 51141570
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C8H5F3N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7LJ087RS6F, chemically known as 2-benzothiazolamine, 6-(trifluoromethoxy)- but generally known as riluzole, which bears US NIH Compound Identifier 5070. European Medicines Agency schedules Riluzole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10319MIG. The term RILUZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules riluzole in its Anatomical Therapeutic Chemical (ATC) Classification. RILUZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule riluzole under HS 29341000 and SITC 51579. As of Q4 2014, RILUZOLE remains the US FDA Preferred Term for this commodity. Riluzole bears US NLM identifiers UMLS ID C0073379 and NCI Concept Code C47704. SMILES: S1C2C(NC1N)CCC(OC(F)(F)F)C2.

